Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (431-440 of 790) with videos related to

Pageof 79
Sort By:
European Journal of Pharmacology|April 22, 1996
Imidazoline binding sites in Huntington's and Parkinson's disease putamenG P Reynolds, R M Boulton, S J Pearson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 11, 2009
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depressionEduard Maron, Anu Tammiste, Kristi Kallassalu, et al.
Neuropharmacology|September 25, 2007
Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonistDavid J Nutt, Marie Besson, Susan J Wilson, et al.
Psychopharmacology|January 1, 1988
Changes in benzodiazepine/GABA receptor complex function in benzodiazepine-tolerant miceD J Nutt, S C Taylor, H J Little, et al.
Molecular Psychiatry|September 27, 2023
Neuroimaging in psychedelic drug development: past, present, and futureMatthew B Wall, Rebecca Harding, Rayyan Zafar, et al.
Pharmacology & Therapeutics|May 24, 2022
Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical researchStephanie L Bourke, Anne Katrin Schlag, Saoirse Elizabeth O'Sullivan, et al.
Psychopharmacology|January 1, 1986
The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptorsP W Glue, P J Cowen, D J Nutt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 1999
Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disordersD J Nutt, S Forshall, C Bell, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2001
Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin releaseM Okada, D J Nutt, T Murakami, et al.
Journal of Neurochemistry|February 16, 2006
Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient miceNeil J Anderson, Isabelle Seif, David J Nutt, et al.
Pageof 79

Showing results (431-440 of 790) with videos related to

Sort By:
Pageof 79
European Journal of Pharmacology|April 22, 1996
Imidazoline binding sites in Huntington's and Parkinson's disease putamenG P Reynolds, R M Boulton, S J Pearson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 11, 2009
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depressionEduard Maron, Anu Tammiste, Kristi Kallassalu, et al.
Neuropharmacology|September 25, 2007
Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonistDavid J Nutt, Marie Besson, Susan J Wilson, et al.
Psychopharmacology|January 1, 1988
Changes in benzodiazepine/GABA receptor complex function in benzodiazepine-tolerant miceD J Nutt, S C Taylor, H J Little, et al.
Molecular Psychiatry|September 27, 2023
Neuroimaging in psychedelic drug development: past, present, and futureMatthew B Wall, Rebecca Harding, Rayyan Zafar, et al.
Pharmacology & Therapeutics|May 24, 2022
Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical researchStephanie L Bourke, Anne Katrin Schlag, Saoirse Elizabeth O'Sullivan, et al.
Psychopharmacology|January 1, 1986
The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptorsP W Glue, P J Cowen, D J Nutt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 1999
Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disordersD J Nutt, S Forshall, C Bell, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2001
Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin releaseM Okada, D J Nutt, T Murakami, et al.
Journal of Neurochemistry|February 16, 2006
Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient miceNeil J Anderson, Isabelle Seif, David J Nutt, et al.
Pageof 79